Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Decibel Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +4 vs. Q3 2021
- Shares held
- 17.6M
- −1.36M (−7.2%) vs. Q3 2021
- Total value
- $81.7M
- −$64.2M (−44.0%) vs. Q3 2021
- New holders
- 10
- 3 more added
- Sold out
- 6
- 12 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $36.4K |
| Q3 2023 | 1 | $36.4K |
| Q2 2023 | 37 | $59.2M |
| Q1 2023 | 38 | $46.7M |
| Q4 2022 | 39 | $35.8M |
| Q3 2022 | 40 | $62.1M |
| Q2 2022 | 42 | $75.2M |
| Q1 2022 | 39 | $53.8M |
| Q4 2021 | 40 | $81.7M |
| Q3 2021 | 36 | $145.9M |
| Q2 2021 | 46 | $168.1M |
| Q1 2021 | 54 | $226.3M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 4,945,192 | $23.0M | 0.30% | 00.0% | Unchanged |
| TRV GP III, LLC | 3,139,685 | $14.6M | 3.65% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,773,561 | $8.25M | 0.01% | −4,098−0.2% | Reduced |
| Alphabet Inc. | 1,636,258 | $7.61M | 0.18% | 00.0% | Unchanged |
| Casdin Capital, LLC | 1,170,048 | $5.44M | 0.15% | 00.0% | Unchanged |
| BlackRock Inc. | 1,096,213 | $5.10M | 0.00% | −725,337−39.8% | Reduced |
| Samsara BioCapital, LLC | 826,422 | $3.84M | 0.77% | 00.0% | Unchanged |
| Vanguard Group Inc | 624,797 | $2.91M | 0.00% | −418−0.1% | Reduced |
| Bessemer Group Inc | 494,071 | $2.30M | 0.00% | 00.0% | Unchanged |
| Harvard Management Co Inc | 328,798 | $1.53M | 0.14% | 00.0% | Unchanged |
| Woodline Partners LP | 275,001 | $1.28M | 0.02% | −5,472−2.0% | Reduced |
| Suvretta Capital Management, LLC | 263,600 | $1.23M | 0.02% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 160,525 | $746.0K | 0.00% | −4,844−2.9% | Reduced |
| Bronte Capital Management Pty Ltd. | 157,216 | $731.0K | 0.09% | −2,246−1.4% | Reduced |
| Bridgeway Capital Management, LLC | 114,928 | $534.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 69,283 | $322.0K | 0.00% | −273−0.4% | Reduced |
| Neuberger Berman Group LLC | 59,570 | $277.0K | 0.00% | +16,035+36.8% | Added |
| Renaissance Technologies LLC | 50,900 | $237.0K | 0.00% | +50,900 | New |
| Two Sigma Investments, LP | 47,368 | $220.0K | 0.00% | +47,368 | New |
| FMR LLC | 43,500 | $202.0K | 0.00% | −170,300−79.7% | Reduced |
| Atlas Capital Advisors LLC | 41,025 | $190.8K | 0.03% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 39,426 | $183.0K | 0.00% | +17,000+75.8% | Added |
| Millennium Management LLC | 38,656 | $180.0K | 0.00% | +120+0.3% | Added |
| Bank of New York Mellon Corp | 27,310 | $127.0K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 18,472 | $86.0K | 0.02% | +18,472 | New |
| State Street Corp | 15,700 | $73.0K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 15,000 | $70.0K | 0.00% | 00.0% | Unchanged |
| Laurion Capital Management LP | 15,053 | $70.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 14,239 | $67.0K | 0.00% | −1,000−6.6% | Reduced |
| Bank of America Corp | 13,723 | $64.0K | 0.00% | −5,550−28.8% | Reduced |
| Morgan Stanley | 13,262 | $62.0K | 0.00% | −14,892−52.9% | Reduced |
| Two Sigma Advisers, LP | 11,300 | $53.0K | 0.00% | +11,300 | New |
| Flagship Harbor Advisors, LLC | 10,113 | $47.0K | 0.00% | +10,113 | New |
| Acadian Asset Management LLC | 4,283 | $19.0K | 0.00% | +4,283 | New |
| Optiver Holding B.V. | 867 | $7.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,409 | $7.00K | 0.00% | +1,409 | New |
| Royal Bank of Canada | 1,075 | $5.00K | 0.00% | −1,000−48.2% | Reduced |
| Citigroup Inc | 751 | $3.00K | 0.00% | +751 | New |
| Financial Connections Group, Inc. | 300 | $1.00K | 0.00% | +300 | New |
| UBS Group AG | 95 | $0 | 0.00% | +95 | New |
| Foresite Capital Management IV, LLC | 0 | $0 | 0.00% | −297,711−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −251,950−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −37,500−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −19,968−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |